Remus Pharmaceuticals Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Remus Pharmaceuticals Ltd is ₹ 685.3 as of 30 Apr 15:30 . The p/e ratio of Remus Pharmaceuticals Ltd changed from 49.4 to 45.4 over 2 quarters. This represents a CAGR of -15.54% The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 4 quarters. This represents a CAGR of -100.00% The market cap of Remus Pharmaceuticals Ltd changed from ₹ 1016 crore to ₹ 1319 crore over 2 quarters. This represents a CAGR of 68.50% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The Revenue of Remus Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Sanofi India Ltd is ₹ 578.9 crore as of Jun '24 . The EBITDA of Remus Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Sanofi India Ltd is ₹ 178.5 crore as of Jun '24 . The Net Profit of Remus Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Sanofi India Ltd is ₹ 136.6 crore as of Jun '24 . The dividend payout of Remus Pharmaceuticals Ltd changed from 2.56 % to 4.44 % over 3 quarters. This represents a CAGR of 108.38% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Remus Pharmaceuticals Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Remus Pharmaceuticals Ltd or Sanofi India Ltd?

Market cap of Remus Pharmaceuticals Ltd is 807 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Remus Pharmaceuticals Ltd and Sanofi India Ltd?

The stock performance of Remus Pharmaceuticals Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Remus Pharmaceuticals Ltd and Sanofi India Ltd?

As of May 3, 2026, the Remus Pharmaceuticals Ltd stock price is INR ₹685.3. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Remus Pharmaceuticals Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Remus Pharmaceuticals Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.